Today, a brief rundown of news involving Bausch + Lomb and Merck & Co., as well as updates from Amgen, AstraZeneca and Asahi Kasei that you may have missed.

First off, I want to start by saying that I DID get a rebate back from Bausch and Lomb for the year's worth of contacts I purchased. My purchase was confirmed fairly quickly and I got my Visa gift ...

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.180 between high and low, or 2.83%. For the ...

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It ...